Trichostatic Acid

Trichostatic Acid

SCHEMBL2380086

CC(/C=C/C(=O)O)=C\C(C)C(=O)c1ccc(N(C)C)cc1

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 10/20 0.74
HDAC3 O15379 7/20 0.74
HDAC4 P56524 7/20 0.74
HDAC7 Q8WUI4 7/20 0.74
HDAC2 Q92769 7/20 0.74
HDAC10 Q969S8 7/20 0.74
HDAC8 Q9BY41 7/20 0.74
HDAC6 Q9UBN7 7/20 0.74
HDAC9 Q9UKV0 7/20 0.74
HDAC5 Q9UQL6 7/20 0.74
HDAC11 Q96DB2 6/20 0.74
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
NR4A1 P22736 1/20 0.46
HPGD P15428 2/20 0.42
MAPT P10636 2/20 0.42
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
CASP3 P42574 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trichostatic Acid SCHEMBL5376359 1.00 HDAC1 (0.74) HDAC1HDAC3HDAC4HDAC7HDAC2
Trichostatic Acid SCHEMBL5376363 1.00 HDAC1 (0.74) HDAC1HDAC3HDAC4HDAC7HDAC2
Trichostatic Acid SCHEMBL13859924 1.00 HDAC1 (0.74) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL12245785 0.90 HDAC1 (0.76) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL13859923 0.87 HDAC1 (0.72) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL8237213 0.87 HDAC1 (0.72) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL2381104 0.85 HDAC1 (0.73) HDAC1HDAC3HDAC4HDAC7HDAC2
Trichostatin SCHEMBL19886 0.85 HDAC1 (1.00) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL2378893 0.85 HDAC1 (0.73) HDAC1HDAC3HDAC4HDAC7HDAC2
Trichostatin SCHEMBL446807 0.85 HDAC1 (1.00) HDAC1HDAC3HDAC4HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237832-A1 SYNTHESIS OF HDAC INHIBITORS: TRICHOSTATIN A AND ANALOGUES UNIVERSITY OF NOTRE DAME DU LAC (US) 2011-09-29 US claimed
US-7235688-B1 Process for preparing histone deacetylase inhibitors and intermediates thereof UNIVERSITY OF NOTRE DAME DU LAC (US) 2007-06-26 US claimed
US-20070021612-A1 Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof UNIVERSITY OF NOTRE DAME DU LAC (US) 2007-01-25 US claimed
EP-0331524-B1 SYNTHESIS OF TRICHOSTATINS Japan Tobacco Inc. (JP) 1993-08-18 EP claimed
EP-0331524-A2 Synthesis of trichostatins Japan Tobacco Inc. (JP) 1989-09-06 EP claimed
JP-1224381-A None JP disclosed
JP-1224381-A None JP disclosed
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
US-20190309289-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2019-10-10 US disclosed
US-10370654-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2019-08-06 US disclosed
US-20180320170-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2018-11-08 US disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 US disclosed
EP-0331524-B1 SYNTHESIS OF TRICHOSTATINS Japan Tobacco Inc. (JP) 1993-08-18 EP disclosed
US-4946999-A Novel intermediates for synthesis of trichostatic acid or trichostatin A, and processes for preparing trichostatic acid and trichostatin A JAPAN TOBACCO INC. (JP) 1990-08-07 US disclosed
US-4946999-A Novel intermediates for synthesis of trichostatic acid or trichostatin A, and processes for preparing trichostatic acid and trichostatin A JAPAN TOBACCO INC. (JP) 1990-08-07 US disclosed
US-4946999-A Novel intermediates for synthesis of trichostatic acid or trichostatin A, and processes for preparing trichostatic acid and trichostatin A JAPAN TOBACCO INC. (JP) 1990-08-07 US disclosed
JP-H01224381-A TRICHOSTATIC ACID, NOVEL SYNTHETIC INTERMEDIATE FOR TRICHOSTATIN A AND PRODUCTION OF TRICHOSTATIC ACID AND TRICHOSTATIN A JAPAN TOBACCO INC 1989-09-07 JP disclosed
JP-H01224381-A TRICHOSTATIC ACID, NOVEL SYNTHETIC INTERMEDIATE FOR TRICHOSTATIN A AND PRODUCTION OF TRICHOSTATIC ACID AND TRICHOSTATIN A JAPAN TOBACCO INC 1989-09-07 JP disclosed
EP-0331524-A2 Synthesis of trichostatins Japan Tobacco Inc. (JP) 1989-09-06 EP disclosed
EP-0331524-A2 Synthesis of trichostatins Japan Tobacco Inc. (JP) 1989-09-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021612-A1 Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof HDAC1, HDAC11, HDAC2 HDAC1 1/4885HDAC3 6/4885HDAC4 11/4885
US-20110237832-A1 SYNTHESIS OF HDAC INHIBITORS: TRICHOSTATIN A AND ANALOGUES HDAC1, HDAC8, HDAC4 HDAC1 1/4885HDAC3 9/4885HDAC4 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.